PRIMECAP Odyssey Aggressive Growth (M:POAGX)

Add to Watchlists
Create an Alert
43.95 -0.19  -0.43% Dec 12 USD
View Full Chart
M:POAGX Total Returns Chart

M:POAGX Key Stats

M:POAGX Performance

  Total Return (Price) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 4.79% 2.96% 3
3M 11.52% 7.13% 2
6M 13.83% 9.85% 6
YTD 31.31% 22.67% 6
1Y 29.14% 20.14% 8
3Y 16.62% 9.81% 1
5Y 22.86% 13.70% 1
10Y 14.60% 7.61% 1
As of Dec. 12, 2017. Returns for periods of 1 year and above are annualized.

M:POAGX Asset Allocation

Type % Net % Long % Short
Cash 2.70% 2.70% 0.00
Stock 96.36% 96.36% 0.00
Bond 0.00 0.00 0.00
Convertible 0.00 0.00 0.00
Preferred 0.95% 0.95% 0.00
Other 0.00 0.00 0.00
As of Sept. 30, 2017

M:POAGX Region Exposure

Americas 92.01%
North America 92.00%
Latin America 0.01%
Greater Europe 0.96%
United Kingdom 0.06%
Europe Developed 0.28%
Europe Emerging 0.00
Africa/Middle East 0.62%
Greater Asia 7.03%
Japan 3.40%
Australasia 0.00
Asia Developed 0.00
Asia Emerging 3.63%
Market Classification
% Developed Markets 96.37%
% Emerging Markets 3.63%
As of Sept. 30, 2017. Region breakdown data is calculated by using the long position holdings of the portfolio.

M:POAGX Stock Sector Exposure

Basic Materials 0.44%
Communication Services 2.20%
Consumer Cyclical 13.86%
Consumer Defensive 1.55%
Energy 0.37%
Financial Services 3.90%
Healthcare 30.13%
Industrials 15.14%
Real Estate 0.00
Technology 32.41%
Utilities 0.00
As of Sept. 30, 2017

M:POAGX Stock Market Capitalization

Giant 11.32%
Large 23.81%
Medium 35.83%
Small 16.79%
Micro 12.25%
As of Sept. 30, 2017

M:POAGX Stock Style Exposure

Large Cap Value 12.41%
Large Cap Blend 8.77%
Large Cap Growth 14.42%
Mid Cap Value 7.89%
Mid Cap Blend 9.37%
Mid Cap Growth 19.57%
Small Cap Value 1.41%
Small Cap Blend 10.76%
Small Cap Growth 15.40%
As of Sept. 30, 2017
View More Holdings

M:POAGX Top 10 Holdings

Symbol Name % Weight Price % Chg
NKTR Nektar Therapeutics Inc 3.74% 56.45 +2.88%
ABMD Abiomed Inc 3.65% 193.08 +0.07%
SNE Sony Corp ADR 3.28% 44.69 +0.13%
MU Micron Technology Inc 3.05% 42.28 +1.00%
BB BlackBerry Ltd 3.01% 10.75 +0.84%
AAL American Airlines Group Inc 2.96% 50.31 -0.32%
RCL Royal Caribbean Cruises Ltd 2.65% 122.80 -0.83%
SGEN Seattle Genetics Inc 2.40% 55.22 +1.12%
ELLI Ellie Mae Inc 2.37% 92.29 +1.25%
ALKS Alkermes PLC 2.33% 52.09 -0.12%
As of Sept. 30, 2017
Advertisement

M:POAGX One Page Reports

M:POAGX Basic Info

Style
Equity Style Mid Cap/Growth
Broad Asset Class US Equity
Broad Category Equity
Category Name Mid-Cap Growth
Prospectus Objective Aggressive Growth
Fund Owner Firm Name PRIMECAP Odyssey Funds
Benchmark Index
S&P 500 TR USD
100.0%

M:POAGX Manager Info

Name Tenure
Alfred Mordecai 12.92 yrs
James Marchetti 2.92 yrs
Joel Fried 12.92 yrs
M. Ansari 5.47 yrs
Theo Kolokotrones 12.92 yrs

M:POAGX Net Fund Flows

1M -5.357M
3M -27.17M
6M -31.88M
YTD 48.08M
1Y 6.989M
3Y -101.03M
5Y 2.419B
10Y 3.346B
As of Nov. 30, 2017

M:POAGX Risk Info

Beta (5Y) 1.167
Historical Sharpe (10Y) 0.7973
Historical Sortino (All) 1.043
Daily Value at Risk (VaR) 1% (All) 3.59%
Monthly Value at Risk (VaR) 1% (All) 17.44%

M:POAGX Fundamentals

Dividend Yield TTM (12-12-17) 0.00
SEC Yield --
Weighted Average PE Ratio 22.38
Weighted Average Price to Sales Ratio 1.903
Weighted Average Price to Book Ratio 3.512
Weighted Median ROE 7.92%
Weighted Median ROA -0.43%
Forecasted Dividend Yield 0.44%
Forecasted PE Ratio 18.13
Forecasted Price to Sales Ratio 1.868
Forecasted Price to Book Ratio 3.152
Number of Holdings 146
As of Sept. 30, 2017

M:POAGX Growth Estimates

Forecasted 5 Yr Earnings Growth 12.03%
Forecasted Book Value Growth 1.21%
Forecasted Cash Flow Growth 17.16%
Forecasted Earnings Growth 6.68%
Forecasted Revenue Growth -1.56%
As of Sept. 30, 2017

M:POAGX Comparables

Edit

M:POAGX Attributes

Purchase Details
Open to New Investors No
Open to Existing Investors Yes
Minimum Initial Investment 2000.00 USD
Minimum Subsequent Investment 100.00 USD
Fees
Actual 12B-1 Fee --
Actual Management Fee 0.55%
Administration Fee --
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load --
Maximum Redemption Fee --
Key Dates
Inception Date 11/1/2004
Last Annual Report Date 10/31/2016
Last Prospectus Date 4/30/2017
Attributes
Exchange Traded Share No
Exchange Traded Note No
Enhanced Index Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

M:POAGX Excel Add-In Codes

  • Name: =YCI("M:POAGX","name")
  • Broad Asset Class: =YCI("M:POAGX", "broad_asset_class")
  • Broad Category: =YCI("M:POAGX", "broad_category_group")
  • Prospectus Objective: =YCI("M:POAGX", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.